Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 300

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Screening for Occult Cancer in Unprovoked Venous Thromboembolism

Carrier, Marc, Lazo-Langner, Alejandro, Shivakumar, Sudeep, Tagalakis, Vicky, Zarychanski, Ryan, Solymoss, Susan, Routhier, Nathalie, Douketis, James, Danovitch, Kim, Lee, Agnes Y., Le Gal, Gregoire, Wells, Philip S., Corsi, Daniel J., Ramsay, Timothy, Coyle, Doug, Chagnon, Isabelle, Kassam, Zahra, Tao, Hardy, Rodger, Marc A.·2015·New England Journal of Medicine

Abstract

BACKGROUND: Venous thromboembolism may be the earliest sign of cancer. Currently, there is a great diversity in practices regarding screening for occult cancer in a person who has an unprovoked venous thromboembolism. We sought to assess the efficacy of a screening strategy for occult cancer that included comprehensive computed tomography (CT) of the abdomen and pelvis in patients who had a first unprovoked venous thromboembolism. METHODS: We conducted a multicenter, open-label, randomized, controlled trial in Canada. Patients were randomly assigned to undergo limited occult-cancer screening (basic blood testing, chest radiography, and screening for breast, cervical, and prostate cancer) or limited occult-cancer screening in combination with CT. The primary outcome measure was confirmed cancer that was missed by the screening strategy and detected by the end of the 1-year follow-up period. RESULTS: Of the 854 patients who underwent randomization, 33 (3.9%) had a new diagnosis of occult cancer between randomization and the 1-year follow-up: 14 of the 431 patients (3.2%) in the limited-screening group and 19 of the 423 patients (4.5%) in the limited-screening-plus-CT group (P=0.28). In the primary outcome analysis, 4 occult cancers (29%) were missed by the limited screening strategy, whereas 5 (26%) were missed by the strategy of limited screening plus CT (P=1.0). There was no significant difference between the two study groups in the mean time to a cancer diagnosis (4.2 months in the limited-screening group and 4.0 months in the limited-screening-plus-CT group, P=0.88) or in cancer-related mortality (1.4% and 0.9%, P=0.75). CONCLUSIONS: The prevalence of occult cancer was low among patients with a first unprovoked venous thromboembolism. Routine screening with CT of the abdomen and pelvis did not provide a clinically significant benefit. (Funded by the Heart and Stroke Foundation of Canada; SOME ClinicalTrials.gov number, NCT00773448.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1506623

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 300

Metadata

Authors
Carrier, M., Lazo-Langner, A., Shivakumar, S., Tagalakis, V., Zarychanski, R., Solymoss, S., Routhier, N., Douketis, J., Danovitch, K., Lee, A. Y., Le Gal, G., Wells, P. S., Corsi, D. J., Ramsay, T., Coyle, D., Chagnon, I., Kassam, Z., Tao, H., & Rodger, M. A.
Venue
New England Journal of Medicine
Published
2015-08-20
Volume
373
Issue
8
Pages
697-704
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2253736303
Cited by
300
References
14
FWCI
45.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening for Occult Cancer in Unprovoked Venous Thromboembolism. https://app.cochat.ai/papers/10.1056/nejmoa1506623
The paper
Carrier, M., Lazo-Langner, A., Shivakumar, S., Tagalakis, V., Zarychanski, R., Solymoss, S., Routhier, N., Douketis, J., Danovitch, K., Lee, A. Y., Le Gal, G., Wells, P. S., Corsi, D. J., Ramsay, T., Coyle, D., Chagnon, I., Kassam, Z., Tao, H., & Rodger, M. A. (2015). Screening for Occult Cancer in Unprovoked Venous Thromboembolism. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1506623

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.